Correlation
The correlation between AMRX and COHR is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
AMRX vs. COHR
Compare and contrast key facts about Amneal Pharmaceuticals, Inc. (AMRX) and Coherent, Inc. (COHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMRX or COHR.
Performance
AMRX vs. COHR - Performance Comparison
Loading data...
Key characteristics
AMRX:
0.22
COHR:
0.38
AMRX:
0.60
COHR:
1.05
AMRX:
1.07
COHR:
1.14
AMRX:
0.09
COHR:
0.51
AMRX:
0.71
COHR:
1.23
AMRX:
11.00%
COHR:
22.89%
AMRX:
35.65%
COHR:
73.64%
AMRX:
-97.52%
COHR:
-80.89%
AMRX:
-85.73%
COHR:
-32.49%
Fundamentals
AMRX:
$3.40B
COHR:
$11.76B
AMRX:
-$0.04
COHR:
-$0.22
AMRX:
1.20
COHR:
2.10
AMRX:
86.10
COHR:
2.20
AMRX:
$2.83B
COHR:
$5.60B
AMRX:
$1.04B
COHR:
$1.93B
AMRX:
$565.78M
COHR:
$888.80M
Returns By Period
In the year-to-date period, AMRX achieves a -7.58% return, which is significantly higher than COHR's -20.16% return. Over the past 10 years, AMRX has underperformed COHR with an annualized return of -17.42%, while COHR has yielded a comparatively higher 14.98% annualized return.
AMRX
-7.58%
-5.43%
-11.49%
9.58%
26.34%
8.49%
-17.42%
COHR
-20.16%
9.34%
-24.49%
32.54%
6.56%
9.74%
14.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMRX vs. COHR — Risk-Adjusted Performance Rank
AMRX
COHR
AMRX vs. COHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and Coherent, Inc. (COHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AMRX vs. COHR - Dividend Comparison
Neither AMRX nor COHR has paid dividends to shareholders.
Drawdowns
AMRX vs. COHR - Drawdown Comparison
The maximum AMRX drawdown since its inception was -97.52%, which is greater than COHR's maximum drawdown of -80.89%. Use the drawdown chart below to compare losses from any high point for AMRX and COHR.
Loading data...
Volatility
AMRX vs. COHR - Volatility Comparison
The current volatility for Amneal Pharmaceuticals, Inc. (AMRX) is 10.62%, while Coherent, Inc. (COHR) has a volatility of 15.22%. This indicates that AMRX experiences smaller price fluctuations and is considered to be less risky than COHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AMRX vs. COHR - Financials Comparison
This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and Coherent, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMRX vs. COHR - Profitability Comparison
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Amneal Pharmaceuticals, Inc. reported a gross profit of 255.89M and revenue of 695.42M. Therefore, the gross margin over that period was 36.8%.
COHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Coherent, Inc. reported a gross profit of 527.69M and revenue of 1.50B. Therefore, the gross margin over that period was 35.2%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Amneal Pharmaceuticals, Inc. reported an operating income of 100.35M and revenue of 695.42M, resulting in an operating margin of 14.4%.
COHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Coherent, Inc. reported an operating income of 145.52M and revenue of 1.50B, resulting in an operating margin of 9.7%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Amneal Pharmaceuticals, Inc. reported a net income of 12.20M and revenue of 695.42M, resulting in a net margin of 1.8%.
COHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Coherent, Inc. reported a net income of 15.71M and revenue of 1.50B, resulting in a net margin of 1.1%.